|
Unknown
|
Unknown |
Novartis AG (NVS) |
NVS |
STOCK |
Sale
|
Jan. 31, 2023 |
$$1,001 - $15,000 |
None |
|
Rohit Khanna
|
house |
CVS HEALTH CORP. COMMON STOCK |
CVS |
STOCK |
Purchase
|
Jan. 16, 2023 |
$1,001 - 15,000 |
March 8, 2022 |
|
Thomas R Carper
|
senate |
CVS Health Corporation Common Stock |
CVS |
STOCK |
Sale (Partial)
|
Jan. 11, 2023 |
$$1,001 - $15,000 |
Feb. 2, 2023 |
|
Daniel S Sullivan
|
senate |
CVS Health Corporation Common Stock |
CVS |
STOCK |
Sale (Partial)
|
Jan. 10, 2023 |
$$1,001 - $15,000 |
Feb. 13, 2023 |
|
Thomas Suozzi
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Sale
|
Nov. 29, 2022 |
$$15,001 - $50,000 |
Dec. 19, 2022 |
|
William J Burns
|
executive |
Novartis |
NVS |
STOCK |
Sale
|
Oct. 24, 2022 |
$$1,001 - $15,000 |
Jan. 31, 2023 |
|
Thomas R Carper
|
senate |
CVS Health Corporation Common Stock |
CVS |
STOCK |
Purchase
|
Oct. 17, 2022 |
$$1,001 - $15,000 |
Nov. 3, 2022 |
|
Kathy Manning
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
July 15, 2022 |
$$1,001 - $15,000 |
Aug. 10, 2022 |
|
Michael T. McCaul
|
house |
Las Vegas Sands Corp Inc |
LVS |
STOCK |
Purchase
|
June 4, 2022 |
$$100,001-$250,000 |
June 14, 2022 |
|
Diana Harshbarger
|
house |
CVS HEALTH CORP |
CVS |
STOCK |
X
|
May 11, 2022 |
$X |
Aug. 31, 2022 |
|
Diana Harshbarger
|
house |
CVS HEALTH CORP |
CVS |
STOCK |
X
|
May 11, 2022 |
$X |
Aug. 31, 2022 |
|
John Rutherford
|
house |
Novartis AG (NVS) |
NVS |
STOCK |
Sale
|
March 16, 2022 |
$$1,001 - $15,000 |
April 19, 2022 |
|
John Rutherford
|
house |
CVS Health Corporation (CVS) [ST] |
CVS |
STOCK |
Sale
|
March 16, 2022 |
$$1,001 - $15,000 |
April 19, 2022 |
|
Michael T. McCaul
|
house |
CVS Health Corp |
CVS |
STOCK |
PURCHASE
|
March 9, 2022 |
$$1,000,001-5,000,000 |
April 18, 2022 |
|
Michael T. McCaul
|
house |
CVS Health Corp |
CVS |
STOCK |
Sale
|
March 9, 2022 |
$$50,001-100,000 |
April 18, 2022 |
|
Michael T. McCaul
|
house |
CVS Health Corp |
CVS |
STOCK |
PURCHASE
|
March 7, 2022 |
$$15,001-100,000 |
March 17, 2022 |
|
Donald Sternoff Beyer
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale
|
Feb. 28, 2022 |
$$1,001 - $15,000 |
March 3, 2022 |
|
Donald Sternoff Beyer
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Sale
|
Feb. 28, 2022 |
$$1,001 - $15,000 |
March 3, 2022 |
|
Michael T. McCaul
|
house |
CVS Health Corp |
CVS |
STOCK |
Purchase
|
Feb. 21, 2022 |
$$250,001-500,000 |
March 17, 2022 |
|
John Rutherford
|
house |
las Vegas Sands Corp. (lVS) |
LVS |
STOCK |
Sale
|
Feb. 17, 2022 |
$$1,001 - $15,000 |
March 16, 2022 |
|
Lois Frankel
|
house |
NuVasive, Inc. (NuVA) |
NVSI |
STOCK |
Sale
|
Feb. 14, 2022 |
$$1,001 - $15,000 |
Feb. 27, 2022 |
|
Michael T. McCaul
|
house |
CVS Health Corp |
CVS |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000.01-$15,000 |
Feb. 23, 2022 |
|
Donald Sternoff Beyer
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Jan. 27, 2022 |
$$1,001 - $15,000 |
Feb. 1, 2022 |
|
Michael T. McCaul
|
house |
Las Vegas Sands Corp |
LVS |
STOCK |
PURCHASE
|
Jan. 18, 2022 |
$$1,000-$15,000 |
Feb. 23, 2022 |
|
Thomas R Carper
|
senate |
CVS Health Corporation Common Stock |
CVS |
STOCK |
Sale (Partial)
|
Jan. 18, 2022 |
$$1,001 - $15,000 |
Feb. 3, 2022 |